Inventor · disambiguated record
Thomas Profitlich
Also filed as: PROFITLICH THOMAS · PROFITLICH THOMAS ALFRED
5 granted patents·5 pending applications·228 citations·filing 1993–2016
81Inventor score
Files withASTELLAS DEUTSCHLAND GMBH2ASTRAZENECA AB2COLLEDGE JEFFREY2KLINGE CO CHEM PHARM FAB1LOHMANN THERAPIE SYST LTS1
Top patents by PatentIndex Score
10 records- 0190US6623759B2Stable drug form for oral administration with benzimidazole derivatives as active ingredient and process for the preparation thereofASTRAZENECA AB·Filed 2001·Granted Sep 23, 2003·70 cites·30 claims
- 0289US6419959B1Galenic composition containing opioid antagonistsKLINGE CO CHEM PHARM FAB·Filed 1997·Granted Jul 16, 2002·150 cites·17 claims
- 0384US7276253B2Stable drug form for oral administration with benzimidazole derivatives as active ingredient and process for the preparation thereofASTRAZENECA AB·Filed 2006·Granted Oct 2, 2007·6 cites·23 claims
- 0466US2012003309A1Solid Dosage Forms Of BendamustineCOLLEDGE JEFFREY·Filed 2009·Application pending·0 cites
- 0556US2014004190A1Solid Dosage Forms of BendamustineCOLLEDGE JEFFREY·Filed 2013·Application pending·0 cites
- 0654US2005064035A1Stable drug form for oral administration with benzimidazole derivatives as active ingredient and process for the preparation thereofFiled 2003·Application pending·0 cites
- 0752US2016106716A1Solid Dosage Forms of BendamustineASTELLAS DEUTSCHLAND GMBH·Filed 2015·Application pending·0 cites
- 0851US11160793B2Solid dosage forms of bendamustineASTELLAS DEUTSCHLAND GMBH·Filed 2016·Granted Nov 2, 2021·0 cites·18 claims
- 0931US2013266658A1Method of producing a PPI-containing pharmaceutical preparationTEMMLER WERKE GMBH·Filed 2013·Application pending·0 cites
- 1029US5698216ATransdermal therapeutic system for the administration of physostigmine to the skin and process for the production thereofLOHMANN THERAPIE SYST LTS·Filed 1993·Granted Dec 16, 1997·2 cites·9 claims
Join the waitlist — get patent alerts
Get an alert when Thomas Profitlich files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →